The global radiopharmaceutical and therapeutics market should reach $22.0 billion by 2023 from $14.1 billion in 2018 at a compound annual growth rate (CAGR) of 9.2% for the period of 2018 to 2023.
Report Scope:
This research report categorizes the radiation therapy by technology, products and applications. The technology market is divided into three types of radiation therapy, which are external beam radiation therapy, internal radiation therapy/brachytherapy and systemic radiation therapy. External radiotherapy’s by-product is LINAC (linear accelerator); compact advanced radiotherapy systems is divided into CyberKnife, gamma knife and tomotherapy, and proton therapy system; and proton therapy system has two subsegments, which are cyclotrons and synchrotrons. Internal radiotherapy is divided into seeds applicators and electronic brachytherapy. External radiotherapy by technology is divided into image-guided radiotherapy (IGRT), intensity modulated radiotherapy (IMRT), stereotactic technology, particle/proton beam therapy, tomotherapy, 3D-conformal radiotherapy (3D-CRT) and volumetric modulated ARC therapy. Internal radiotherapy by technology is divided into two types: low-dose brachytherapy and high-dose brachytherapy. Systemic radiation therapy is bifurcated into two segments: alpha emitters and beta emitters.
Radiation therapy has also been studied based on the various applications: external radiation therapy applications: prostate cancer, breast cancer, lung cancer, and head and neck cancer. Internal radiation therapy applications include: prostate cancer, gynecological cancer, breast cancer, cervical cancer and systemic radiation therapy, hyperthyroidism, bone metastasis, lymphoma and endocrine tumors. The global radiation therapy market is segmented in this report by region: North America, Europe, Asia and the Rest of the World.
Report Includes:
- An overview of the global market for radiotherapy and related technologies and applications.
- Analyses of market trends with data from 2016, estimates for 2017, and projections of compound annual growth rates (CAGRs) through 2022.
- Discussion of major factors driving the growth for nuclear medicine, including neurological diseases such as Alzheimer's disease, Parkinson's disease, and dementia, and an overall increase in awareness about nuclear medicine.
- Detailed information concerning major challenges the market faces, including the harmful effects of radiation, the tight required regulation of radioisotopes, and a lack of supply of radioisotopes.
- Analyses of the diagnostic applications for radiotherapy, such as Single Photon Emission Computed Tomography (SPECT) and Positron Emission Tomography (PET).
- Comprehensive company profiles of major players in the industry.
Report Summary
There are currently 33 million cancer patients worldwide and this number is steadily increasing as the global population ages. The market for radiotherapy, one of the treatments used in oncology, was estimated at nearly $6.8 billion in 2017 and is expected to increase at a compound annual growth rate (CAGR) of 6.4% to $9.2 billion by 2022. The radiation therapy market is bifurcated with two main players, Varian and Elekta, which dominate more than 90% of the market. Major players include Varian
(U.S.), Elekta (Sweden), IBA-Worldwide Proton Therapy (Belgium) and Accuray (U.S.).
Several major drivers are expected to boost the growth of this market in the forecasted period, including government funding through constant reimbursement continuous R&D applied to different applications; and the fact that radiation therapy is an efficient treatment. The rising incidence of cancer due to aging populations, particularly in developing countries, is another major driver since aging is considered the biggest single factor for the development of cancer. Additionally, radiation therapy is a personalized treatment, which is preferred in cancer cases.
Major factors restricting the growth of the radiation therapy market, particularly in developing countries, are the high cost of the devices, space restrictions and the lack of trained professionals to administer it. External radiation therapy claims the major share of the global market, but the equipment is capital intensive and requires a large facility to accommodate it. Other factors that have a negative effect on the market include radiation therapy's limited effectiveness against metastatic cancer and its
side effects.
Since this is a capital-intensive industry, a stable economy is a necessity for growth. Half of all cancer cases are occurring in developing countries, many of which have strong economies. This enables them to have the purchasing power to buy equipment. The major threat is economic downturn or recession; the radiation therapy market saw a major dip during the recession of 2009.
The global radiation therapy market is segmented by type into three submarkets: external beam radiation therapy, internal beam radiation therapy/brachytherapy and systemic radiation therapy. The radiation therapy market is estimated by application of each type of therapy and by region into the North America, Europe, Asia and the Rest of the World.
The radiation therapy market is growing at a CAGR of 6.4% due to growth in developing countries and replacement sales in developed countries.
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Related BCC Research Reports
Chapter 2 Summary and Highlights
Chapter 3 Market and Technology Background
Introduction to Cancer
Introduction to Radiation
History of Radiation Therapy
Mechanism of Action
Risk Management and Quality Assurance in Radiation Therapy
Radiation Therapy Market Segmentation
Drivers, Restraints, Opportunities and Trends
Market Share Analysis
Different Cancer Treatments
Definition
Benign Tumors
Malignant Tumors
Other Types of Cancers
Causes of Cancer
Cancer Protective Factors and Risk Factors
Non-Ionizing Radiation
Ionizing Radiation
Particle Radiation
The Discovery Period
Kilovoltage Era (1900-1940)
Megavoltage Era (1946-1996)
Computer-assisted Era (1996-2017)
Cell Growth Cycle
Drivers
Restraints
Opportunity
Trends
Threat
Metastasis
Malignant Tumor Categories
Carcinomas
Sarcomas
Internal Factors
External Factors
Electron Beams
Proton Beams
Neutron Beams
Carbon Ions
Alpha and Beta Particles
Photon Radiations
Gamma Rays
X-rays
Increasing Incidences of Cancer
High Incidence of Cancer in Aging Population
High Efficiency of Radiotherapy
Palliative Radiation Therapy
Government Funding
Advancement in Technology
Reimbursement Boosting Market Growth
Cost Effective
Huge Gap
Capital Intensive
Lack of Trained Professionals
Limited Effectiveness Against Metastatic Cancer
Side Effects Associated with Radiation Therapy
Therapeutic Bottlenecks
Developing Countries
Personalized Treatment
Replacement of Old Equipment
Respiratory Gating
Proton Therapy
Carbon Ions
MR LINAC
Recession
Chapter 4 Market Breakdown by Product Type
Introduction
External Beam Radiation Therapy
Internal Radiation Therapy
Treatment Planning for External Beam Radiation
Electron-Emitting High-Energy Linear Accelerators (LINACS)
Compact Advance Radiotherapy Systems
Proton Therapy System
Dosing and Treatment with External Beam Radiation
Structure of Linear Accelerators
Electron Guns
The Buncher
The LINACS
Magnetrons
Klystrons
Beam Collimation and Monitoring
CyberKnife
Gamma Knife
Mechanism of Action
Tomotherapy
Cyclotrons
Synchrotrons
Chapter 5 Market Breakdown by Technology
External Radiotherapy Market by Technology
Internal Radiotherapy by Technology
Systemic Radiotherapy by Technology
Particle Therapy/Proton Beam Therapy
Stereotactic Radiosurgery (SRS) and Fractionated Stereotactic Radiation Therapy
Image-guided Radiation Therapy (IGRT)
Intensity-modulated Radiation Therapy (IMRT)
Three-dimensional Conformal Radiation Therapy (3D-CRT)
Volumetric Modulated Arc Therapy (VMAT)
PDR Brachytherapy
Low Dose Rate Brachytherapy
High Dose Rate Brachytherapy
Comparison Between Alpha and Beta Emitters
High Costs Restricts the Use
Chapter 6 Market Breakdown by Application
External Beam Radiation Therapy Market
Internal Radiation Therapy Market by Application
Systemic Radiation Therapy
Prostate Cancer
Breast Cancer
Lung Cancer
Head and Neck Cancer
Other Cancers
Prostate Cancer
Head and Neck Cancer
Gynecological Cancer
Breast Cancer
Cervical Cancer
Hyperthyroidism
Bone Metastases
Lymphoma
Endocrine Tumors
Life Expectancy
Overall Health Status
Tumor Characteristics
Stage I Prostate Cancer
Stage II Prostate Cancer
Stage III Prostate Cancer
Stage IV Prostate Cancer
Personal Preferences
Advantages of EBRT in Treating Prostate Cancer
Side Effects
Disadvantages
Types of Lung Cancer
Non-Small Cell Lung Cancer
Small Cell Lung Cancer
Lung Carcinoid Tumor
Conformal Radiation Therapy (CRT)
Vaginal Cancer
Chapter 7 Market Breakdown by Region
Introduction
North America
Europe
Asia
United States
Canada
Japan
China
India
Rest of the World
Latin America
Middle East
Africa
Chapter 8 Competitive Landscape
New Products Launches and Product Enhancement
Agreement, Partnerships, Collaboration and Contract Approvals
Mergers and Acquisitions
Other Developments
Chapter 9 Company Profiles
ACCURAY INCORPORATED
ACTINIUM PHARMACEUTICALS
AUSTRALIAN NUCLEAR SCIENCE AND TECHNOLOGY ORGANISATION
C. R. BARD, INC.
ECKERT & ZIEGLER BEBIG
ELEKTA
GE HEALTHCARE
IBA MOLECULAR
NORDION INC.
NTP RADIOISOTOPES
SIEMENS HEALTHCARE
VARIAN MEDICAL SYSTEMS
Chapter 10 Appendix
Seeds
Applicators and Afterloaders
External Brachytherapy
Systemic Radiotherapy
Cumbersome Regulatory Requirements
Alpha Emitters
Beta Emitters